Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quercetin Nanoemulgel in Periodontitis
NCT05928546Phase 1Not yet recruiting
- Sponsor
- Assiut University
- Start
- Feb 2024
- Primary completion
- May 2024
- Modality
- Allosteric Modulators, Orthosteric Ligands
01
Overview
Phase 1, randomised, open-label trial of quercetin in periodontitis (2 arms), sponsored by Assiut University. Primary endpoints: Clinical Attachment Loss at 3 months, Probing Depth at 3 months and 2 more. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
quercetin
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT05928546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05928546.